National brain tumour research funding needs to increase to £35 million a year
Plymouth welcomes supporters sponsoring a day
Today we are welcoming supporters to our Centre of Excellence within the University of Plymouth, where principal investigator Professor Oliver Hanemann is leading cutting-edge research being conducted into low-grade brain tumours.
Scientists at Plymouth are focusing on the emerging area of personalised medicine in order to provide new understanding of common, low-grade brain tumours like astrocytoma, oligodendroglioma, schwannoma, meningioma and ependymoma. Research into low-grade brain tumours is vital because these tumours frequently have life-changing consequences for patients, can be terminal and also may become high-grade over time.
Katie Ann-Dunn, 30, is one of our guests who will be particularly interested to gain insights into potential breakthroughs as she was diagnosed in 2021 with a meningioma, the most common brain tumour in adults. Katie underwent two surgeries as well as fertility preservation before starting radiotherapy.
Between surgery and treatment for her meningioma, Katie and her family raised almost £3,000 for Brain Tumour Research by taking part last year in 10,000 Steps a Day in February. Katie, accompanied by Maxine Smith, James Everett and Steve Smith will be putting up a tile on the Wall of Hope – a symbol that her fundraising is sponsoring the equivalent of one day of research.
Read an update from the day on our blog later this week
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.